Pacira BioSciences, Inc. (PCRX) valuation · rev $726.4M
Pacira BioSciences, Inc. (PCRX) rev $726.4M.
| Metric | Value |
|---|---|
| Market cap | $890.8M |
| Revenue | $726.4M |
| P/S | 1.2 |
| P/B | 1.4 |
PCRX valuation FAQ
What is PCRX's market cap?
Pacira BioSciences, Inc. (PCRX) market cap is $890.8M on the latest cached fundamentals snapshot.
What is PCRX's latest revenue?
Latest cached Pacira BioSciences, Inc. (PCRX) revenue was $726.4M. Statements: https://lician.com/financials/pcrx
What is PCRX's price-to-sales ratio?
Pacira BioSciences, Inc. (PCRX) price-to-sales (P/S) is 1.2, cached market cap $890.8M divided by revenue $726.4M.
What is PCRX's price-to-book ratio?
Pacira BioSciences, Inc. (PCRX) price-to-book (P/B) is 1.4 on the latest cached fundamentals snapshot.
How many PCRX valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Pacira BioSciences, Inc. (PCRX): Market cap, Revenue, P/S, and P/B.
Where is PCRX valuation listed?
Cached valuation multiples for Pacira BioSciences, Inc. (PCRX) are listed at https://lician.com/valuation/pcrx.
Not investment advice. Cached rows, not a live tape.